ENO2 and prostate cancer: The lack of expression of the prostate-specific genes (AR, NKX3.1, and PSA) at the protein level prompted the investigation of a possible NE prostate cancer phenotype, which was confirmed at the RNA-seq level when 2 NE specific marker (SYP and ENO2) were expressed at RNA-seq.